May 3, 2019
Dear Colleagues,
I am pleased to present the second edition of our Office of Partnerships Stakeholder Newsletter!
The stakeholder newsletter from the Office of Partnerships (OP) was designed with our many domestic and international governmental partners in mind with the goal of increasing awareness of the vast array of functions, services, and opportunities provided by OP as we work in collaboration with our ORA and FDA center partners.
This edition highlights some of the key programs and resources coordinated by OP, as well as quick facts, recent accomplishments, and a calendar of upcoming events that may be of interest to our regulatory and public health partners. You will find that links are provided to allow for readers to access more detailed information on specific programs, initiatives, or resources with just one click.
As we are committed to practicing continuous process improvement (even in our newsletter!), we welcome your thoughts, ideas, and suggestions at [email protected]. We’d love to hear from you!
We hope this newsletter provides a useful resource for sharing information and increasing awareness, thus strengthening our collaborative relationships with federal, state, local, tribal, territorial (SLTT), and international partners. I am proud to highlight the excellent work underway in OP, working collaboratively with our SLTT and internal ORA/FDA center partners, to advance public health. I am continually impressed by what talented and dedicated staff across all levels of government can accomplish together. I look forward to what the future has in store for our continued success.
Sincerely,
Barbara J. Cassens
Director, Office of Partnerships
Office of Regulatory Affairs
U.S. Food and Drug Administration
Our Vision: A global partnership that protects public health.
Our Mission: We make partnerships happen by fostering funding opportunities and promoting domestic and international mutual reliance and systems recognition.
http://www.fda.gov/regulatorypartners
This message is being broadcast by the Division of Communications in FDA’s Office of Regulatory Affairs (ORA).
Thank you,
FDA/ORA
Office of Communications and Project Management
Division of Communications
Mailbox: [email protected]
|